Emodin-induced microglial apoptosis is associated with TRB3 induction

Area of Science:

• Neuroscience
• Immunology
• Pharmacology

Background:

• Emodin, a natural compound from rhubarb, shows promise in treating brain injury.
• Emodin's effects on neurons are known, but its impact on brain immune cells (microglia) is unclear.
• Microglia play a crucial role in neuroinflammation and brain injury.

Purpose of the Study:

• To investigate the effects of emodin on microglial activation and apoptosis.
• To elucidate the molecular mechanisms underlying emodin's action on microglia.
• To assess emodin's potential for treating brain injury via microglial modulation.

Main Methods:

• Utilized the BV-2 mouse microglial cell line.
• Assessed cell viability and apoptosis using luminescence assays and caspase activity.
• Measured inflammatory marker expression via quantitative RT-PCR.
• Investigated the role of TRB3 using siRNA knockdown and ectopic overexpression.
• Analyzed the Akt/FOXO3 pathway.

Main Results:

• Emodin induced dose-dependent, caspase-mediated apoptosis in BV-2 cells.
• Emodin enhanced lipopolysaccharide (LPS)-induced microglial apoptosis, reducing inflammatory activation.
• Emodin increased reactive oxygen species (ROS) production and activated TRB3.
• TRB3 knockdown attenuated emodin-induced apoptosis; TRB3 overexpression impaired cell viability and dysregulated the Akt/FOXO3 pathway.
• Emodin-induced apoptosis in microglia was mediated by TRB3 activation.

Conclusions:

• Emodin induces microglial apoptosis through the TRB3 pathway, leading to the elimination of inflammatory microglia.
• This TRB3-mediated apoptosis provides a novel molecular mechanism for emodin's neuroprotective effects in brain injury.
• Emodin represents a potential therapeutic agent for intracerebral hemorrhage by modulating microglial activity.